Author of the publication

Classical major histocompatibility complex class I molecules in motoneurons: new actors at the neuromuscular junction.

, , , , , and . The journal of neuroscience, 29 (43): 13503-13515 (October 2009)
DOI: 10.1523/JNEUROSCI.0981-09.2009

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Systems-level immunomonitoring from acute to recovery phase of severe COVID-19, , , , , , , , , and 10 other author(s). Cell Reports Medicine, (2020)SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults, , , , , , , , , and 22 other author(s). Journal of Allergy and Clinical Immunology, (2021)Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures, , , , , , , , , and 6 other author(s). (January 2022)Immune-microbe interactions early in life: A determinant of health and disease long term. Science, 376 (6596): 945--950 (May 2022)The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19, , , , , , , , , and 13 other author(s). Cell, (2020)Unraveling the Immune Response in Severe COVID-19, and . Journal of Clinical Immunology, 40 (7): 958--959 (Oct 1, 2020)Classical major histocompatibility complex class I molecules in motoneurons: new actors at the neuromuscular junction., , , , , and . The journal of neuroscience, 29 (43): 13503-13515 (October 2009)Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy., , , , , , , , , and 1 other author(s). Haematologica, 100 (11): 1477-1485 (November 2015)Stereotypic Immune System Development in Newborn Children, , , , , , , , , and 1 other author(s). Cell, 174 (5): 1277 - 1292.e14 (2018)Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'., , , , , , , , , and 3 other author(s). ELife, (June 2019)